BioCentury
ARTICLE | Company News

Competitive Technologies Inc., Dade Behring deal

September 5, 2005 7:00 AM UTC

CTT granted DADE a license to its U.S. Patent No. 4,940,658 and ex-U.S. counterparts covering homocysteine tests for cardiovascular diseases. CTT will receive a license fee and is eligible for royalti...